(1)
Study the Technical Validity and Feasibility of Serum HER-2 Neu and Its Correlation With Tissue HER-2 Status in Female Breast Cancer Patients Only. Asian J Med Sci 2023, 14 (11), 228-233. https://doi.org/10.3126/ajms.v14i11.55260.